Abstract Metallic devices are broadly employed as biomaterials, equating to 70-80% of implants globally, however, there is a critical need to develop devices with minimal failure rates with annual costs of revision surgeries estimated to be $1.62 billion in 2020. Additive manufacturing (AM) has been the lead disruptor in orthopaedic device fabrication as a result of […]